Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies
This Research Topic was focused on provision of novel medical technologies worldwide keeping in mind financial sustainability challenge. An exemplary area certainly are oncology pharmaceuticals where prices have increased 10-fold in recent years leading to concerns on affordability. The objective of...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Online |
| Språk: | engelska |
| Utgiven: |
Frontiers Media SA
2021
|
| Ämnen: | |
| Länkar: | 29710 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
| _version_ | 1869520008100446208 |
|---|---|
| author | Tetsuji Yamada Mihajlo (Michael) Jakovljevic |
| author_browse | Mihajlo (Michael) Jakovljevic Tetsuji Yamada |
| author_facet | Tetsuji Yamada Mihajlo (Michael) Jakovljevic |
| author_sort | Tetsuji Yamada |
| collection | Directory of Open Access Books |
| description | This Research Topic was focused on provision of novel medical technologies worldwide keeping in mind financial sustainability challenge. An exemplary area certainly are oncology pharmaceuticals where prices have increased 10-fold in recent years leading to concerns on affordability. The objective of this collection of studies was to reveal some of the hidden underlying causes of unequal access to the medicines. Another core issue is the growing proportion of out-of-pocket health spending in many world regions. In line with the joint efforts of the editors and authors we received an exceptionally high response worldwide. This E-Book attracted a total of 37 self-standing research submissions out of which 32 ultimately passed external peer review and got published. Base affiliations of the authors spread across academia, pharmaceutical and medical device industry, governmental authorities and clinical medicine. Their home institutions were situated in fifteen different countries inclusive of Japan, Israel, Russia, USA, Germany, Italy, Netherlands, Austria, Spain, Malta, Serbia, Poland, Bulgaria, Hungary and Malaysia. We frankly believe that authors succeeded to cover important literature gaps referring to these world regions. We solicit global professional audience to put our efforts to the test and read this contribution to the health economics literature. |
| format | Online |
| id | doab-20.500.12854ir-58584 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media SA |
| publisherStr | Frontiers Media SA |
| record_format | ojs |
| spelling | doab-20.500.12854ir-585842024-04-01T14:14:54Z Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies Tetsuji Yamada Mihajlo (Michael) Jakovljevic RM1-950 Q1-390 Decision Making health technology assessment Health Economics cost health policy Health expenditure Resource Allocation health investment reimbursement medical technology Emerging Markets thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology This Research Topic was focused on provision of novel medical technologies worldwide keeping in mind financial sustainability challenge. An exemplary area certainly are oncology pharmaceuticals where prices have increased 10-fold in recent years leading to concerns on affordability. The objective of this collection of studies was to reveal some of the hidden underlying causes of unequal access to the medicines. Another core issue is the growing proportion of out-of-pocket health spending in many world regions. In line with the joint efforts of the editors and authors we received an exceptionally high response worldwide. This E-Book attracted a total of 37 self-standing research submissions out of which 32 ultimately passed external peer review and got published. Base affiliations of the authors spread across academia, pharmaceutical and medical device industry, governmental authorities and clinical medicine. Their home institutions were situated in fifteen different countries inclusive of Japan, Israel, Russia, USA, Germany, Italy, Netherlands, Austria, Spain, Malta, Serbia, Poland, Bulgaria, Hungary and Malaysia. We frankly believe that authors succeeded to cover important literature gaps referring to these world regions. We solicit global professional audience to put our efforts to the test and read this contribution to the health economics literature. 2021-02-12T02:27:45Z 2021-02-12T02:27:45Z 2018-11-22 11:34:28 2017 book 29710 16648714 9782889453207 https://directory.doabooks.org/handle/20.500.12854/58584 eng Frontiers Research Topics image/jpeg Attribution 4.0 International https://www.frontiersin.org/research-topics/4338/role-of-health-economic-data-in-policy-making-and-reimbursement-of-new-medical-technologies Frontiers Media SA 10.3389/978-2-88945-320-7 10.3389/978-2-88945-320-7 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889453207 202 open access |
| spellingShingle | RM1-950 Q1-390 Decision Making health technology assessment Health Economics cost health policy Health expenditure Resource Allocation health investment reimbursement medical technology Emerging Markets thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Tetsuji Yamada Mihajlo (Michael) Jakovljevic Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies |
| title | Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies |
| title_full | Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies |
| title_fullStr | Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies |
| title_full_unstemmed | Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies |
| title_short | Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies |
| title_sort | role of health economic data in policy making and reimbursement of new medical technologies |
| topic | RM1-950 Q1-390 Decision Making health technology assessment Health Economics cost health policy Health expenditure Resource Allocation health investment reimbursement medical technology Emerging Markets thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | RM1-950 Q1-390 Decision Making health technology assessment Health Economics cost health policy Health expenditure Resource Allocation health investment reimbursement medical technology Emerging Markets thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | 29710 |
| work_keys_str_mv | AT tetsujiyamada roleofhealtheconomicdatainpolicymakingandreimbursementofnewmedicaltechnologies AT mihajlomichaeljakovljevic roleofhealtheconomicdatainpolicymakingandreimbursementofnewmedicaltechnologies |